Sage Stock Sinks After FDA Decision on Depression Drug

Subscribe to our newsletter

Sage Stock Sinks After FDA Decision on Depression Drug  Barron’sFirst FDA approved drug helping women through postpartum depression  WQAD News 8FDA approves Zurzuvae, first treatment for postpartum depression  TODAYBiogen, Sage face challenges as FDA rejects pill for clinical depression  ReutersNBC 10 News Today: F-D-A approves first-ever oral medication to treat postpartum depression  KTVE…
Read More